130 related articles for article (PubMed ID: 18043915)
1. Marine lysozyme from a marine bacterium that inhibits angiogenesis and tumor growth.
Ye J; Wang C; Chen X; Guo S; Sun M
Appl Microbiol Biotechnol; 2008 Jan; 77(6):1261-7. PubMed ID: 18043915
[TBL] [Abstract][Full Text] [Related]
2. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
3. Lebectin, a Macrovipera lebetina venom-derived C-type lectin, inhibits angiogenesis both in vitro and in vivo.
Pilorget A; Conesa M; Sarray S; Michaud-Levesque J; Daoud S; Kim KS; Demeule M; Marvaldi J; El Ayeb M; Marrakchi N; Béliveau R; Luis J
J Cell Physiol; 2007 May; 211(2):307-15. PubMed ID: 17323383
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of tumor angiogenesis by targeting endothelial surface ATP synthase with sangivamycin.
Komi Y; Ohno O; Suzuki Y; Shimamura M; Shimokado K; Umezawa K; Kojima S
Jpn J Clin Oncol; 2007 Nov; 37(11):867-73. PubMed ID: 17956898
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of in vivo angiogenesis by N-beta-alanyl-5-S-glutathionyl-3,4-dihydroxyphenylalanine.
Nishikawa T; Akiyama N; Kunimasa K; Oikawa T; Ishizuka M; Tsujimoto M; Natori S
Eur J Pharmacol; 2006 Jun; 539(3):151-7. PubMed ID: 16725138
[TBL] [Abstract][Full Text] [Related]
6. Antiangiogenesis and anticancer efficacy of TA138, a novel alphavbeta3 antagonist.
Mousa SA; Mohamed S; Wexler EJ; Kerr JS
Anticancer Res; 2005; 25(1A):197-206. PubMed ID: 15816539
[TBL] [Abstract][Full Text] [Related]
7. Mammalian tumor xenografts induce neovascularization in zebrafish embryos.
Nicoli S; Ribatti D; Cotelli F; Presta M
Cancer Res; 2007 Apr; 67(7):2927-31. PubMed ID: 17409396
[TBL] [Abstract][Full Text] [Related]
8. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
[TBL] [Abstract][Full Text] [Related]
9. Digoxin inhibits neuroblastoma tumor growth in mice.
Svensson A; Azarbayjani F; Bäckman U; Matsumoto T; Christofferson R
Anticancer Res; 2005; 25(1A):207-12. PubMed ID: 15816540
[TBL] [Abstract][Full Text] [Related]
10. Nonclinical antiangiogenesis and antitumor activities of axitinib (AG-013736), an oral, potent, and selective inhibitor of vascular endothelial growth factor receptor tyrosine kinases 1, 2, 3.
Hu-Lowe DD; Zou HY; Grazzini ML; Hallin ME; Wickman GR; Amundson K; Chen JH; Rewolinski DA; Yamazaki S; Wu EY; McTigue MA; Murray BW; Kania RS; O'Connor P; Shalinsky DR; Bender SL
Clin Cancer Res; 2008 Nov; 14(22):7272-83. PubMed ID: 19010843
[TBL] [Abstract][Full Text] [Related]
11. Natural antioxidant pedicularioside G inhibits angiogenesis and tumourigenesis in vitro and in vivo.
Mu P; Gao X; Jia ZJ; Zheng RL
Basic Clin Pharmacol Toxicol; 2008 Jan; 102(1):30-4. PubMed ID: 17973903
[TBL] [Abstract][Full Text] [Related]
12. Levamisole inhibits angiogenesis in vitro and tumor growth in vivo.
Friis T; Engel AM; Klein BM; Rygaard J; Houen G
Angiogenesis; 2005; 8(1):25-34. PubMed ID: 16132615
[TBL] [Abstract][Full Text] [Related]
13. Broad antitumor activity in breast cancer xenografts by motesanib, a highly selective, oral inhibitor of vascular endothelial growth factor, platelet-derived growth factor, and Kit receptors.
Coxon A; Bush T; Saffran D; Kaufman S; Belmontes B; Rex K; Hughes P; Caenepeel S; Rottman JB; Tasker A; Patel V; Kendall R; Radinsky R; Polverino A
Clin Cancer Res; 2009 Jan; 15(1):110-8. PubMed ID: 19118038
[TBL] [Abstract][Full Text] [Related]
14. A low molecular weight polysaccharide isolated from Agaricus blazei suppresses tumor growth and angiogenesis in vivo.
Niu YC; Liu JC; Zhao XM; Wu XX
Oncol Rep; 2009 Jan; 21(1):145-52. PubMed ID: 19082455
[TBL] [Abstract][Full Text] [Related]
15. Identification of campesterol from Chrysanthemum coronarium L. and its antiangiogenic activities.
Choi JM; Lee EO; Lee HJ; Kim KH; Ahn KS; Shim BS; Kim NI; Song MC; Baek NI; Kim SH
Phytother Res; 2007 Oct; 21(10):954-9. PubMed ID: 17604370
[TBL] [Abstract][Full Text] [Related]
16. Expression, purification, and bioactivity of human tumstatin from Escherichia coli.
Gu Q; Zhang T; Luo J; Wang F
Protein Expr Purif; 2006 Jun; 47(2):461-6. PubMed ID: 16503164
[TBL] [Abstract][Full Text] [Related]
17. Ganoderma tsugae extract inhibits expression of epidermal growth factor receptor and angiogenesis in human epidermoid carcinoma cells: In vitro and in vivo.
Hsu SC; Ou CC; Chuang TC; Li JW; Lee YJ; Wang V; Liu JY; Chen CS; Lin SC; Kao MC
Cancer Lett; 2009 Aug; 281(1):108-16. PubMed ID: 19332363
[TBL] [Abstract][Full Text] [Related]
18. Pyrrolo[2,3-α]carbazole derivatives as topoisomerase I inhibitors that affect viability of glioma and endothelial cells in vitro and angiogenesis in vivo.
Lampropoulou E; Manioudaki M; Fousteris M; Koutsourea A; Nikolaropoulos S; Papadimitriou E
Biomed Pharmacother; 2011 Jun; 65(3):142-50. PubMed ID: 21616631
[TBL] [Abstract][Full Text] [Related]
19. Anti-angiogenesis effect of essential oil from Curcuma zedoaria in vitro and in vivo.
Chen W; Lu Y; Gao M; Wu J; Wang A; Shi R
J Ethnopharmacol; 2011 Jan; 133(1):220-6. PubMed ID: 20920565
[TBL] [Abstract][Full Text] [Related]
20. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.
Mousa SA; Bergh JJ; Dier E; Rebbaa A; O'Connor LJ; Yalcin M; Aljada A; Dyskin E; Davis FB; Lin HY; Davis PJ
Angiogenesis; 2008; 11(2):183-90. PubMed ID: 18080776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]